Loading...
Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma
BACKGROUND & AIM: In clinical practice, transarterial chemoembolization (TACE) has been widely used for the treatment of hepatocellular carcinoma (HCC) beyond as well as within guideline recommendations. Here we aimed to verify whether two consecutive non-responses could be an optimal criterion...
Saved in:
| Published in: | PLoS One |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Public Library of Science
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7055892/ https://ncbi.nlm.nih.gov/pubmed/32130270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0229696 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|